Stockscreener 앱 받기
1.52
2.70%
0.04
MAIA Biotechnology Inc 주식(MAIA)의 최신 뉴스
Published on: 2025-08-04 17:15:59 - metal.it
How volatile is MAIA Biotechnology Inc. stock compared to the marketBuild wealth with proven stock investing tactics - Jammu Links News
What analysts say about MAIA Biotechnology Inc. stockMaster stock selection with insider knowledge - Jammu Links News
Why is MAIA Biotechnology Inc. stock attracting strong analyst attentionGet timely alerts on top market movers - Jammu Links News
What institutional investors are buying MAIA Biotechnology Inc. stockAchieve consistent profits with smart trading - Jammu Links News
Should I hold or sell MAIA Biotechnology Inc. stock in 2025Maximize gains with strategic stock entries - Jammu Links News
What makes MAIA Biotechnology Inc. stock price move sharplyIdentify winners with top-tier analysis - Jammu Links News
MAIA Biotechnology Inc. Stock Analysis and ForecastMaximize your portfolio’s growth potential - Jammu Links News
What catalysts could drive MAIA Biotechnology Inc. stock higher in 2025Unlock powerful insights from market experts - Jammu Links News
Is MAIA Biotechnology Inc. a growth stock or a value stockMaximize portfolio value with timely trades - Jammu Links News
What is the dividend policy of MAIA Biotechnology Inc. stockAchieve rapid portfolio appreciation - Jammu Links News
Best Momentum Stocks to Buy for May 6th - The Globe and Mail
Is MAIA Biotechnology Inc. stock overvalued or undervaluedNavigate the market with precision tools - Jammu Links News
How does MAIA Biotechnology Inc. generate profit in a changing economyInvest confidently with real-time data analysis - Jammu Links News
MAIA Biotechnology Announces FDA Fast Track For First-in-Class Telomere-Targeting Drug In NSCLC; Latest Data In Pivotal Phase 2 THIO-101 Clinical Trial Shows Median Overall Survival Of 17.8 Months - 富途牛牛
What are analysts’ price targets for MAIA Biotechnology Inc. in the next 12 monthsBest Dividend Entry Points For Every Investor - Jammu Links News
Does MAIA Biotechnology Inc. stock perform well during market downturnsTop Growth Alerts With Proven Results - Jammu Links News
What are the latest earnings results for MAIA Biotechnology Inc.Daily Trading Picks Backed By Experts - jammulinksnews.com
Buy Signal for MAIA Biotechnology Inc. Stock Key Technical Indicators to WatchConservative Long Term Growth Plans Under Review - beatles.ru
Maia Biotechnology shares jump after FDA awards Fast Track status - MSN
Can MAIA Biotechnology Inc. recover in the next quarterTrade Timing Strategy With Technical Data Explained - metal.it
Will MAIA Biotechnology Inc. benefit from macro trendsPredictive AI Engine for Smart Investing - Newser
Key resistance and support levels for MAIA Biotechnology Inc.Real-Time AI Sentiment and Price Forecast - Newser
RSI Crosses Above 30 for MAIA Biotechnology Inc. — Reversal in SightWeekly Watchlist of High Movers Released - metal.it
Is MAIA Biotechnology Inc. stock a growth or value playSector Rotation Outlook With Historical Summary - Newser
Why MAIA Biotechnology Inc. stock attracts strong analyst attentionProfit Target Stock Opportunity Monitor Activated - metal.it
How to escape a deep drawdown in MAIA Biotechnology Inc.Asset Growth Pattern and Return Summary - Newser
Using RSI to spot recovery in MAIA Biotechnology Inc.Weekly Hot Stocks Based on Volume Flow - Newser
Will MAIA Biotechnology Inc. Hold Gains Into CloseShort Term High Yield Stock Tips for Active Traders - metal.it
Sm Energy Company shares rise 1.09% premarket after MAIA Biotechnology receives FDA's Fast Track designation for ateganosine. - AInvest
MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine - Contract Pharma
MAIA Biotechnology’s Ateganosine Receives FDA Fast Track - TipRanks
MAIA Biotechnology and the Ateganosine Opportunity in NSCLC: Assessing the Fast Track Designation as a Catalyst for Accelerated Value Creation in a High-Growth Oncology Market - AInvest
Maia Biotechnology shares rise 11.18% premarket after receiving FDA's Fast Track designation for ateganosine. - AInvest
Maia Biotechnology receives FDA's fast track designation for Ateganosine as a treatment for non-small cell lung cancer - MarketScreener
Maia Biotechnology stock soars after FDA grants Fast Track designation - Investing.com Australia
Maia Biotechnology stock soars after FDA grants Fast Track designation By Investing.com - Investing.com South Africa
MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer - Business Wire
Maia Biotechnology, Inc. Receives Fda's Fast Track Designation for Ateganosine as A Treatment for Non-Small Cell Lung Cancer - MarketScreener
0.24%
3.39%
자본화:
|
볼륨(24시간):